Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
$1.54
-4.9%
$1.34
$3.01
$13.40
$6.22M-0.0820,837 shs194,958 shs
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.42
-4.2%
$0.49
$0.19
$1.01
$10.50M1.2135,924 shs78,150 shs
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
$0.24
+8.6%
$0.21
$0.12
$3.67
$10.46M0.03821,202 shs68.67 million shs
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
$0.91
-1.6%
$2.82
$0.67
$16.25
$2.38M1.761.60 million shs291,853 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
0.00%+9.22%+27.27%-9.94%-85.67%
Biotricity, Inc. stock logo
BTCY
Biotricity
0.00%-20.19%-18.63%-5.14%-56.32%
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
0.00%0.00%-5.39%-31.58%-93.30%
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
0.00%-9.80%-17.86%-78.35%-88.62%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/AN/AN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/AN/AN/AN/AN/AN/AN/AN/A
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
0.0582 of 5 stars
0.02.00.00.00.00.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
0.00
N/AN/AN/A
Biotricity, Inc. stock logo
BTCY
Biotricity
2.00
HoldN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
0.00
N/AN/AN/A
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/AN/A
Biotricity, Inc. stock logo
BTCY
Biotricity
$12.06M0.87N/AN/A($1.30) per share-0.32
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
$64.47M0.18N/AN/A($0.80) per share-0.30
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
$2.56M0.91N/AN/A$1.84 per share0.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Biotricity, Inc. stock logo
BTCY
Biotricity
-$14.09M-$1.08N/AN/A-80.42%N/A-188.47%6/25/2025 (Estimated)
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
-$8.44M-$0.30N/AN/A-13.59%N/A-25.97%N/A
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
-$3.70M-$13.53N/AN/A-210.82%-54.73%-38.63%8/13/2025 (Estimated)

Latest NAOV, DHAI, BLAC, and BTCY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/25/2025N/A
Biotricity, Inc. stock logo
BTCY
Biotricity
-$0.10N/AN/AN/A$3.60 millionN/A
5/20/2025Q1 2025
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
N/A-$3.98N/A-$3.98N/A$1.02 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/A
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/AN/AN/AN/AN/A
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/A
Biotricity, Inc. stock logo
BTCY
Biotricity
N/A
0.23
0.10
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/A
0.51
0.34
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
N/A
0.47
0.22

Institutional Ownership

CompanyInstitutional Ownership
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
55.30%
Biotricity, Inc. stock logo
BTCY
Biotricity
3.89%
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
27.76%
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
16.39%

Insider Ownership

CompanyInsider Ownership
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
33.67%
Biotricity, Inc. stock logo
BTCY
Biotricity
10.10%
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
49.58%
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
7.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/A4.04 million2.68 millionNot Optionable
Biotricity, Inc. stock logo
BTCY
Biotricity
4024.91 million22.08 millionOptionable
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/A47.34 million23.87 millionN/A
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
202.58 million2.40 millionNot Optionable

Recent News About These Companies

NanoVibronix appoints new CEO after acquisition
NanoVibronix Announces CEO Transition
NanoVibronix Responds to False Post
NanoVibronix Regains Nasdaq Compliance
NanoVibronix, Inc.
NanoVibronix announces board member resignation
NanoVibronix announces UroShield health service study data published

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bellevue Life Sciences Acquisition stock logo

Bellevue Life Sciences Acquisition NASDAQ:BLAC

$1.54 -0.08 (-4.94%)
As of 06/20/2025

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Biotricity stock logo

Biotricity NASDAQ:BTCY

$0.42 -0.02 (-4.23%)
As of 03:32 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

DIH Holding US stock logo

DIH Holding US NASDAQ:DHAI

$0.24 +0.02 (+8.60%)
Closing price 04:00 PM Eastern
Extended Trading
$0.23 -0.01 (-5.83%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

Nanovibronix stock logo

Nanovibronix NASDAQ:NAOV

$0.91 -0.01 (-1.62%)
Closing price 04:00 PM Eastern
Extended Trading
$0.89 -0.02 (-1.67%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.